1-15 of 15
Rogier Mous
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2023-181707
Published: 2023
Journal Articles

Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

Nick Veltmaat, Geok Wee Tan, Johanna A.A. Bult, Yujie Zhong, Wouter J. Plattel, Rogier Mous, Pim Mutsaers, Wendy B.C. Stevens, Joost S.P. Vermaat, Martine E.D. Chamuleau, Arjan Diepstra, Anke Van Den Berg, Filipe Montes De Jesus, Marcel Nijland
Journal: Blood
Blood (2022) 140 (Supplement 1): 9274–9276.
https://doi.org/10.1182/blood-2022-171213
Published: 2022
Journal Articles

Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

Ymke van der Pol, Steven Wang, Norbert Moldovan, A.Vera de Jonge, Esther E.E. Drees, Margaretha Roemer, Bauke Ylstra, Marcel Nijland, Marjolein W.M. Van Der Poel, Koen de Heer, Clara Klerk, Rozemarijn van Rijn, Rob Fijnheer, Vibeke K.J. Vergote, Aart Beeker, Laurens Nieuwenhuizen, Rogier Mous, Joost S.P. Vermaat, D. Michiel Pegtel, Martine E.D. Chamuleau, Florent Mouliere
Journal: Blood
Blood (2022) 140 (Supplement 1): 3529–3531.
https://doi.org/10.1182/blood-2022-168668
Published: 2022
Journal Articles

A Propensity Score-Adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for MYC -Rearranged DLBCL Patients

A. Vera de Jonge, Erik D. van Werkhoven, Avinash G. Dinmohamed, Marcel Nijland, Aeilko H. Zwinderman, Patrick M. Bossuyt, Martine S. Veldhuis, Emma G.G.M. Rutten, Rogier Mous, Joost S.P. Vermaat, Yorick Sandberg, Eva de Jongh, Yavuz M. Bilgin, Rinske Boersma, Harry R. Koene, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau
Journal: Blood
Blood (2022) 140 (Supplement 1): 2059–2060.
https://doi.org/10.1182/blood-2022-163204
Published: 2022
Journal Articles

First-Line Treatment and Outcome of T-Cell Prolymphocytic Leukemia in the Netherlands; A Nationwide Population-Based Study

Mirian Brink, Arie C. van der Spek, Koen de Heer, Sabina Kersting, Lidwine W. Tick, Hanneke M. van der Straaten, Rogier Mous, Mark-David Levin, Doreen te Raa, Michel van Gelder, Jeanette K. Doorduijn, Arnon P. Kater, Gerwin Huls, Mar Bellido
Journal: Blood
Blood (2022) 140 (Supplement 1): 3788–3789.
https://doi.org/10.1182/blood-2022-168849
Published: 2022
Journal Articles

Time-Limited Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Who Have Undetectable MRD - Primary Analysis from the Randomized Phase II Vision HO141 Trial

Carsten Utoft Niemann, Julie Dubois, Christian Brieghel, Sabina Kersting, Lisbeth Enggaard, Gerrit J Veldhuis, Rogier Mous, Clemens Mellink, Johan A Dobber, Christian Bjørn Poulsen, Henrik Frederiksen, Ann Janssens, Ida Schjødt, Ellen C Dompeling, Juha Ranti, Mattias Mattsson, Mar Bellido, Kazem Nasserinejad, Hoa Thi Tuyet Tran, Mark-David Levin, Arnon P. Kater
Journal: Blood
Blood (2021) 138 (Supplement 1): 69.
https://doi.org/10.1182/blood-2021-148630
Published: 2021
Journal Articles

Siremadlin (HDM201) Is Well Tolerated and Demonstrates Clinical Activity in Patients with Acute Myeloid Leukemia Who Have Relapsed after Allogeneic Stem Cell Transplantation: A Subset Analysis of Safety and Preliminary Efficacy

Eytan M. Stein, Jörg Chromik, Cecilia Carpio, Rogier Mous, Jean-Jacques Kiladjian, Gheath Alatrash, Antonio Curti, Charles Craddock, Christoph Schmid, Robert Zeiser, Lamis K. Eldjerou, Hans-Jochen Jochen Weber, Claire Fabre, Jeffrey Scott, Daniel J. DeAngelo
Journal: Blood
Blood (2021) 138 (Supplement 1): 3417.
https://doi.org/10.1182/blood-2021-149751
Published: 2021
Journal Articles

Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

Clinical Trials & Observations
Carsten U. Niemann, Mark-David Levin, Julie Dubois, Sabina Kersting, Lisbeth Enggaard, Gerrit J. Veldhuis, Rogier Mous, Clemens H. M. Mellink, Johan A. Dobber, Christian B. Poulsen, Henrik Frederiksen, Ann Janssens, Ida Schjødt, Ellen C. Dompeling, Juha Ranti, Mattias Mattsson, Mar Bellido, Hoa T. T. Tran, Kazem Nasserinejad, Arnon P. Kater
Journal: Blood
Blood (2021) 137 (8): 1117–1120.
https://doi.org/10.1182/blood.2020008608
Published: 2021
Includes: Supplemental data
Journal Articles

Subcutaneous Epcoritamab Induces Complete Responses with an Encouraging Safety Profile across Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Subtypes, Including Patients with Prior CAR-T Therapy: Updated Dose Escalation Data

Martin Hutchings, MD PhD, Rogier Mous, MD PhD, Michael Roost Clausen, MD PhD, Peter Johnson, MD FRCP, Kim M Linton, MBChB, PhD, Martine E.D. Chamuleau, MD PhD, David John Lewis, MD, Anna Sureda Balari, MD PhD, David Cunningham, MD FRCP, FMedSci, Roberto S Oliveri, MD PhD, Dena DeMarco, Brian Elliott, MD, Kuo-mei Chen, PhD, Pieternella J. Lugtenburg, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-133820
Published: 2020
Journal Articles

Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) - 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial

Carsten Utoft Niemann, MD PhD, Julie Dubois, Sabina Kersting, MD PhD, Lisbeth Enggaard, MD, Gerrit J Veldhuis, Rogier Mous, MD PhD, Clemens Mellink, PhD, Johan A Dobber, Christian Bjørn Poulsen, MD, Henrik Frederiksen, MD Prof, Ann Janssens, Ida Schjødt, MD PhD, Ellen C Dompeling, Juha Ranti, Mattias Mattsson, MD, Mar Bellido, Hoa T Tran, Kazem Nasserinejad, Mark-David Levin, MD PhD, Arnon P. Kater, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4292.
https://doi.org/10.1182/blood-2019-124377
Published: 2019
Journal Articles

First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody ® -CD3×CD20) in B-Cell Non-Hodgkin Lymphomas

Pieternella Lugtenburg, MD PhD, Rogier Mous, MD PhD, Michael Roost Clausen, Martine E.D. Chamuleau, Peter Johnson, MDFRCP, Kim Linton, PhD, Simon Rule, Roberto S Oliveri, MD PhD, Dena DeMarco, Ida H Hiemstra, PhD, Guang Chen, Ada Azaryan, Manish Gupta, Tahamtan Ahmadi, Martin Hutchings, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 758.
https://doi.org/10.1182/blood-2019-121460
Published: 2019
Journal Articles

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Martine E.D. Chamuleau, MD, Marcel Nijland, MD, Josée M Zijlstra, MD, Rogier Mous, MD PhD, P.J. Lugtenburg, Daan Dierickx, MD PhD, Gustaaf van Imhoff, MD PhD, Joost Vermaat, MD PhD, Katerina Bakunina, Erik W.A. Marijt, MD, Otto Visser, MDPhD, Caroline Mandigers, MD, Yavuz Bilgin, MDPhD, Coreline Burggraaff, Otto Hoekstra, MDPhD, Daphne de Jong, Prof Dr, Marie José Kersten, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 786.
https://doi.org/10.1182/blood-2018-99-110240
Published: 2018
Journal Articles

Ibrutinib: A Risk Factor for Invasive Fungal Infections?

Rosa Ruchlemer, MD, Ronen Ben Ami, MD, Maskit Bar-Meir, Jennifer R. Brown, MD PhD, Marion Malphettes, MD, Rogier Mous, MD PhD, Sanne Tonino, MD PhD, Carole Soussain, MD PhD, Noelie Barzic, Julia A. Messina, MD, Preetesh Jain, MBBS,MDDM,PhD, Regev Cohen, MD, Brian T. Hill, MD PhD, Stephen Mulligan, PhDFRACP,FRCPA,MBBS, Marcel Nijland, MD, Yair Herishanu, MD, Ohad Benjamini, MD, Tamar Tadmor, MD, Koh Okamoto, MD, Benjamin Arthurs, MD, Jacob M. Rowe, MB, BS, Tamar Lachish, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4323.
https://doi.org/10.1182/blood.V130.Suppl_1.4323.4323
Published: 2017
Journal Articles

Enhanced Formation and Survival of Regulatory T Cells in CLL.

Margot Jak, Rogier Mous, Ester BM Remmerswaal, René Spijker, Annelieke Jaspers, Adriana Yagüe, Eric Eldering, René A.W. van Lier, Marinus H. J. van Oers
Journal: Blood
Blood (2008) 112 (11): 1065.
https://doi.org/10.1182/blood.V112.11.1065.1065
Published: 2008
Journal Articles

Redirection of CMV Specific CTL towards B-CLL Via CD20 Targeted HLA/CMV Complexes.

Rogier Mous, MD, Philip Savage Savage, MD, Ester BM Remmerswaal, Rene A.W. van Lier, MD, PhD, Eric Eldering, Marinus H.J. Van Oers, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 449.
https://doi.org/10.1182/blood.V106.11.449.449
Published: 2005